US Stock MarketDetailed Quotes

PVLA Palvella Therapeutics

Watchlist
  • 11.800
  • -0.200-1.67%
Close Dec 24 13:00 ET
  • 11.800
  • 0.0000.00%
Post 17:01 ET
164.37MMarket Cap5.99P/E (TTM)

Palvella Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Total revenue
0
0
0
0
Operating revenue
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-61.26%1.76M
-34.21%11.87M
4.54M
18.04M
Selling and administrative expenses
-16.13%775K
-25.99%3.08M
--924K
--4.16M
-General and administrative expense
-16.13%775K
-25.99%3.08M
--924K
--4.16M
Research and development costs
-72.79%984K
-36.67%8.79M
--3.62M
--13.88M
Operating profit
61.26%-1.76M
34.21%-11.87M
-4.54M
-18.04M
Net non-operating interest income expense
68.79%-805K
160.45%6.27M
-2.58M
-10.36M
Non-operating interest expense
-68.79%805K
----
--2.58M
----
Total other finance cost
----
-160.45%-6.27M
----
--10.36M
Other net income (expense)
-93.12%28K
14,062.64%24.3M
407K
-174K
Gain on sale of security
31.76%-58K
261.67%485K
---85K
---300K
Other non- operating income (expenses)
-82.52%86K
18,796.83%23.81M
--492K
--126K
Income before tax
62.22%-2.54M
165.40%18.69M
-6.71M
-28.58M
Income tax
0
0
0
-1.03M
Net income
62.22%-2.54M
167.84%18.69M
-6.71M
-27.55M
Net income continuous Operations
62.22%-2.54M
167.84%18.69M
---6.71M
---27.55M
Minority interest income
Net income attributable to the parent company
62.22%-2.54M
167.84%18.69M
-6.71M
-27.55M
Preferred stock dividends
0.00%194K
776K
194K
Other preferred stock dividends
Net income attributable to common stockholders
60.47%-2.73M
165.02%17.92M
-6.91M
-27.55M
Basic earnings per share
60.47%-0.2433
165.02%1.5965
-0.6154
-2.4553
Diluted earnings per share
60.47%-0.2433
165.02%1.5965
-0.6154
-2.4553
Dividend per share
Currency Unit
USD
USD
USD
USD
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Total revenue 0000
Operating revenue --0--0--0--0
Cost of revenue
Gross profit
Operating expense -61.26%1.76M-34.21%11.87M4.54M18.04M
Selling and administrative expenses -16.13%775K-25.99%3.08M--924K--4.16M
-General and administrative expense -16.13%775K-25.99%3.08M--924K--4.16M
Research and development costs -72.79%984K-36.67%8.79M--3.62M--13.88M
Operating profit 61.26%-1.76M34.21%-11.87M-4.54M-18.04M
Net non-operating interest income expense 68.79%-805K160.45%6.27M-2.58M-10.36M
Non-operating interest expense -68.79%805K------2.58M----
Total other finance cost -----160.45%-6.27M------10.36M
Other net income (expense) -93.12%28K14,062.64%24.3M407K-174K
Gain on sale of security 31.76%-58K261.67%485K---85K---300K
Other non- operating income (expenses) -82.52%86K18,796.83%23.81M--492K--126K
Income before tax 62.22%-2.54M165.40%18.69M-6.71M-28.58M
Income tax 000-1.03M
Net income 62.22%-2.54M167.84%18.69M-6.71M-27.55M
Net income continuous Operations 62.22%-2.54M167.84%18.69M---6.71M---27.55M
Minority interest income
Net income attributable to the parent company 62.22%-2.54M167.84%18.69M-6.71M-27.55M
Preferred stock dividends 0.00%194K776K194K
Other preferred stock dividends
Net income attributable to common stockholders 60.47%-2.73M165.02%17.92M-6.91M-27.55M
Basic earnings per share 60.47%-0.2433165.02%1.5965-0.6154-2.4553
Diluted earnings per share 60.47%-0.2433165.02%1.5965-0.6154-2.4553
Dividend per share
Currency Unit USDUSDUSDUSD
Heat List
US
Overall
Symbol
Price
% Chg

No Data